Literature DB >> 18367009

Lipoproteini lipase-derived fatty acids: physiology and dysfunction.

Jee Lee1, Ira J Goldberg.   

Abstract

Under normal circumstances, most energy substrate used for heart contraction derives from fatty acids in the form of nonesterified fatty acids bound to albumin or fatty acids derived from lipolysis of lipoprotein-bound triglyceride by lipoprotein lipase (LpL). By creating LpL knockout mice (hLpL0), we learned that loss of cardiac LpL leads to myocardial dysfunction; therefore, neither nonesterified fatty acids nor increased glucose metabolism can replace LpL actions. hLpL0 mice do not survive abdominal aortic constriction and they develop more heart failure with hypertension. Conversely, we created a mouse overexpressing cardiomyocyte-anchored LpL. This transgene produced cardiac lipotoxicity and dilated cardiomyopathy. Methods to alter this phenotype and the causes of other models of lipotoxicity are currently being studied and will provide further insight into the physiology of lipid metabolism in the heart.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18367009     DOI: 10.1007/s11906-007-0085-4

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  35 in total

1.  Failure of the nonselective beta-blocker propranolol to affect lipoprotein lipase gene expression in the rat.

Authors:  I Gouni-Berthold; K Oka; H K Berthold; L Chan
Journal:  Lipids       Date:  1997-09       Impact factor: 1.880

2.  Lipoprotein lipase activity and mRNA are up-regulated by refeeding in adipose tissue and cardiac muscle of sheep.

Authors:  M Bonnet; C Leroux; Y Faulconnier; J F Hocquette; F Bocquier; P Martin; Y Chilliard
Journal:  J Nutr       Date:  2000-04       Impact factor: 4.798

3.  Inhibition of cardiac lipoprotein utilization by transgenic overexpression of Angptl4 in the heart.

Authors:  Xinxin Yu; Shawn C Burgess; Hongfei Ge; Kenny K Wong; R Haris Nassem; Daniel J Garry; A Dean Sherry; Craig R Malloy; Joel P Berger; Cai Li
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-19       Impact factor: 11.205

4.  Aging-induced decrease in the PPAR-alpha level in hearts is improved by exercise training.

Authors:  Motoyuki Iemitsu; Takashi Miyauchi; Seiji Maeda; Takumi Tanabe; Masakatsu Takanashi; Yoko Irukayama-Tomobe; Satoshi Sakai; Hajime Ohmori; Mitsuo Matsuda; Iwao Yamaguchi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-11       Impact factor: 4.733

5.  The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus.

Authors:  Brian N Finck; John J Lehman; Teresa C Leone; Michael J Welch; Michael J Bennett; Attila Kovacs; Xianlin Han; Richard W Gross; Ray Kozak; Gary D Lopaschuk; Daniel P Kelly
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

6.  Myocardial dysfunction and male mortality in peroxisome proliferator-activated receptor alpha knockout mice overexpressing lipoprotein lipase in muscle.

Authors:  Christa Nöhammer; Friedrich Brunner; Gerald Wölkart; Philipp B Staber; Ernst Steyrer; Frank J Gonzalez; Rudolf Zechner; Gerald Hoefler
Journal:  Lab Invest       Date:  2003-02       Impact factor: 5.662

7.  Apolipoprotein B production reduces lipotoxic cardiomyopathy: studies in heart-specific lipoprotein lipase transgenic mouse.

Authors:  Masayoshi Yokoyama; Hiroaki Yagyu; Yunying Hu; Toru Seo; Kumiko Hirata; Shunichi Homma; Ira J Goldberg
Journal:  J Biol Chem       Date:  2003-11-21       Impact factor: 5.157

8.  CD36 deficiency rescues lipotoxic cardiomyopathy.

Authors:  John Yang; Nandakumar Sambandam; Xianlin Han; Richard W Gross; Michael Courtois; Attila Kovacs; Maria Febbraio; Brian N Finck; Daniel P Kelly
Journal:  Circ Res       Date:  2007-03-15       Impact factor: 17.367

9.  Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy.

Authors:  Hiroaki Yagyu; Guangping Chen; Masayoshi Yokoyama; Kumiko Hirata; Ayanna Augustus; Yuko Kako; Toru Seo; Yunying Hu; E Peer Lutz; Martin Merkel; André Bensadoun; Shunichi Homma; Ira J Goldberg
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

Review 10.  Peroxisome proliferator-activated receptor gamma in diabetes and metabolism.

Authors:  Shamina M Rangwala; Mitchell A Lazar
Journal:  Trends Pharmacol Sci       Date:  2004-06       Impact factor: 14.819

View more
  4 in total

Review 1.  The vascular contribution to Alzheimer's disease.

Authors:  Robin Altman; John C Rutledge
Journal:  Clin Sci (Lond)       Date:  2010-08-05       Impact factor: 6.124

2.  Multiple pathways ensure retinoid delivery to milk: studies in genetically modified mice.

Authors:  Sheila M O'Byrne; Yuko Kako; Richard J Deckelbaum; Inge H Hansen; Krzysztof Palczewski; Ira J Goldberg; William S Blaner
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-12-29       Impact factor: 4.310

3.  Arsenic-induced dyslipidemia in male albino rats: comparison between trivalent and pentavalent inorganic arsenic in drinking water.

Authors:  Olusegun K Afolabi; Adedoja D Wusu; Olabisi O Ogunrinola; Esther O Abam; David O Babayemi; Oluwatosin A Dosumu; Okechukwu B Onunkwor; Elizabeth A Balogun; Olusegun O Odukoya; Oladipo Ademuyiwa
Journal:  BMC Pharmacol Toxicol       Date:  2015-06-05       Impact factor: 2.483

4.  Absence of ANGPTL4 in adipose tissue improves glucose tolerance and attenuates atherogenesis.

Authors:  Binod Aryal; Abhishek K Singh; Xinbo Zhang; Luis Varela; Noemi Rotllan; Leigh Goedeke; Balkrishna Chaube; Joao-Paulo Camporez; Daniel F Vatner; Tamas L Horvath; Gerald I Shulman; Yajaira Suárez; Carlos Fernández-Hernando
Journal:  JCI Insight       Date:  2018-03-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.